Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer
Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France; Early Cancer Institute, Department of Oncology, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States.
Show others and affiliations
2024 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 35, no 6, p. 523-536Article in journal (Refereed) Published
Abstract [en]

Background: The incidence of early-onset colorectal cancer (EOCRC; diagnosed <50 years of age) is rising globally; however, the causes underlying this trend are largely unknown. CRC has strong genetic and environmental determinants, yet common genetic variants and causal modifiable risk factors underlying EOCRC are unknown. We conducted the first EOCRC-specific genome-wide association study (GWAS) and Mendelian randomization (MR) analyses to explore germline genetic and causal modifiable risk factors associated with EOCRC.

Patients and methods: We conducted a GWAS meta-analysis of 6176 EOCRC cases and 65 829 controls from the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), the Colorectal Transdisciplinary Study (CORECT), the Colon Cancer Family Registry (CCFR), and the UK Biobank. We then used the EOCRC GWAS to investigate 28 modifiable risk factors using two-sample MR.

Results: We found two novel risk loci for EOCRC at 1p34.1 and 4p15.33, which were not previously associated with CRC risk. We identified a deleterious coding variant (rs36053993, G396D) at polyposis-associated DNA repair gene MUTYH (odds ratio 1.80, 95% confidence interval 1.47-2.22) but show that most of the common genetic susceptibility was from noncoding signals enriched in epigenetic markers present in gastrointestinal tract cells. We identified new EOCRC-susceptibility genes, and in addition to pathways such as transforming growth factor (TGF) β, suppressor of Mothers Against Decapentaplegic (SMAD), bone morphogenetic protein (BMP) and phosphatidylinositol kinase (PI3K) signaling, our study highlights a role for insulin signaling and immune/infection-related pathways in EOCRC. In our MR analyses, we found novel evidence of probable causal associations for higher levels of body size and metabolic factors—such as body fat percentage, waist circumference, waist-to-hip ratio, basal metabolic rate, and fasting insulin—higher alcohol drinking, and lower education attainment with increased EOCRC risk.

Conclusions: Our novel findings indicate inherited susceptibility to EOCRC and suggest modifiable lifestyle and metabolic targets that could also be used to risk-stratify individuals for personalized screening strategies or other interventions.

Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 35, no 6, p. 523-536
Keywords [en]
early-onset colorectal cancer, genetics, GWAS, Mendelian randomization, risk factors
National Category
Medical Genetics and Genomics Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-224251DOI: 10.1016/j.annonc.2024.02.008ISI: 001263365300001PubMedID: 38408508Scopus ID: 2-s2.0-85190961629OAI: oai:DiVA.org:umu-224251DiVA, id: diva2:1857974
Available from: 2024-05-15 Created: 2024-05-15 Last updated: 2025-02-10Bibliographically approved

Open Access in DiVA

fulltext(1693 kB)86 downloads
File information
File name FULLTEXT02.pdfFile size 1693 kBChecksum SHA-512
5feb8d4743737b15ac6683024967479a0cb7e41b549bdb829e160f9c1a20481ce01a2565ffaec6db90eb41e1bce3ea493d491ec0550f9df5f5586acec1f7c8c2
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

van Guelpen, Bethany

Search in DiVA

By author/editor
van Guelpen, Bethany
By organisation
Wallenberg Centre for Molecular Medicine at Umeå University (WCMM)Oncology
In the same journal
Annals of Oncology
Medical Genetics and GenomicsCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 113 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 295 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf